GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $143.51 $159.34 Friday, 19th Apr 2024 ALNY stock ended at $144.41. This is 0.517% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 2.38% from a day low at $143.51 to a day high of $146.92.
90 days $143.51 $191.72
52 weeks $143.51 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
2023-11-24 $162.76 $166.23 $162.27 $162.92 142 980
2023-11-22 $165.20 $167.50 $161.51 $162.88 299 369
2023-11-21 $164.92 $166.54 $161.33 $163.68 484 925
2023-11-20 $163.82 $170.83 $163.38 $165.26 511 816
2023-11-17 $168.54 $169.59 $163.37 $163.73 654 477
2023-11-16 $171.10 $171.99 $167.50 $168.97 433 740
2023-11-15 $169.22 $174.00 $169.22 $171.05 455 332
2023-11-14 $169.97 $172.42 $168.52 $169.99 721 904
2023-11-13 $161.95 $165.06 $159.51 $165.01 334 190
2023-11-10 $165.33 $166.55 $157.84 $161.89 658 706
2023-11-09 $169.14 $169.61 $163.03 $164.52 605 477
2023-11-08 $170.67 $170.67 $166.13 $169.40 496 292
2023-11-07 $168.92 $172.98 $167.57 $170.20 636 035
2023-11-06 $168.99 $169.22 $164.35 $167.15 492 151
2023-11-03 $164.68 $169.12 $164.21 $167.35 653 400
2023-11-02 $162.34 $163.27 $148.73 $161.53 753 809
2023-11-01 $151.94 $157.21 $149.29 $157.00 785 623
2023-10-31 $150.00 $152.26 $148.27 $151.80 574 548
2023-10-30 $151.47 $155.94 $150.84 $151.41 605 862
2023-10-27 $154.18 $154.95 $151.17 $151.76 623 796
2023-10-26 $159.49 $159.51 $155.26 $155.66 637 112
2023-10-25 $161.86 $162.80 $159.00 $159.49 467 881
2023-10-24 $162.49 $166.00 $161.17 $163.96 371 253
2023-10-23 $161.57 $163.54 $160.46 $162.00 339 924
2023-10-20 $161.33 $163.52 $159.50 $161.79 731 932
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT